Fig. 2From: Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathwayThe proliferative inhibition effect of matrine, cisplatin and the combination on the UBC cells. Drug concentration-cell viability curves were drawn as the viable cell percentage based on the cell viability assay (a, c, e, g). The synergistic effects between matrine and cisplatin were exhibited as Fa-CI plots (b, d, f, h). Data are from three repeated experiments with quadruplicate wells (mean ± SD). *P < 0.05, **P < 0.01, or ***P < 0.001 versus the control groupBack to article page